NEUROINMUNOLOGÍA
Tohoku Medical and Pharmaceutical University Hospital
Sendai, JapónPublikationen in Zusammenarbeit mit Forschern von Tohoku Medical and Pharmaceutical University Hospital (1)
2021
-
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD
Annals of Neurology, Vol. 89, Núm. 6, pp. 1088-1098